Cargando…
Orofacial neuropathic pain induced by oxaliplatin: Downregulation of KCNQ2 channels in V2 trigeminal ganglion neurons and treatment by the KCNQ2 channel potentiator retigabine
Neuropathic pain induced by chemotherapy drugs such as oxaliplatin is a dose-limiting side effect in cancer treatment. The mechanisms underlying chemotherapy-induced neuropathic pain are not fully understood. KCNQ2 channels are low-threshold voltage-gated K(+) channels that play a role in controllin...
Autores principales: | Ling, Jennifer, Erol, Ferhat, Viatchenko-Karpinski, Viacheslav, Kanda, Hirosato, Gu, Jianguo G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549876/ https://www.ncbi.nlm.nih.gov/pubmed/28741430 http://dx.doi.org/10.1177/1744806917724715 |
Ejemplares similares
-
Molecular Insights Into Binding and Activation of the Human KCNQ2 Channel by Retigabine
por: Garofalo, Barbara, et al.
Publicado: (2022) -
KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia
por: Abd-Elsayed, Alaa A, et al.
Publicado: (2015) -
Down-regulation of Kv4.3 channels and a-type K(+) currents in V2 trigeminal ganglion neurons of rats following oxaliplatin treatment
por: Viatchenko-Karpinski, Viacheslav, et al.
Publicado: (2018) -
Electro-mechanical coupling of KCNQ channels is a target of epilepsy-associated mutations and retigabine
por: Yang, Nien-Du, et al.
Publicado: (2022) -
KCNQ2 and KCNQ5 form heteromeric channels independent of KCNQ3
por: Soh, Heun, et al.
Publicado: (2022)